​Grand Rounds/Webinars

 

Resource Name
  
Resource Date
  
Core/Team
  
Description
Grand Rounds 54: 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial (Slides)3/20/2025Special Grand Rounds
(Slides) In this Grand Rounds, Malaz Boustani, MD, MPH, discusses transforming brain health with early detection of cognitive problems in the primary care setting using the 5-cog paradigm.
Grand Rounds 54: 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial (Video)3/20/2025Special Grand Rounds
(Video) In this Grand Rounds, Malaz Boustani, MD, MPH, discusses transforming brain health with early detection of cognitive problems in the primary care setting using the 5-cog paradigm.
Grand Rounds 52: Improving Advance Care Planning for Seriously Ill Primary Care Patients: UC Health Care Planning Study (Video)1/16/2025Special Grand Rounds
(Video) In this Grand Rounds, Rebecca Sudore, MD, and Anne Walling, MD, PhD, discuss the evolving Advance Care Planning (ACP) definition and research along with lessons learned from their ACP PCORI pragmatic randomized control trial.
Grand Rounds 52: Improving Advance Care Planning for Seriously Ill Primary Care Patients: UC Health Care Planning Study (Slides)1/16/2025Special Grand Rounds
(Slides) In this Grand Rounds, Rebecca Sudore, MD, and Anne Walling, MD, PhD, discuss the evolving Advance Care Planning (ACP) definition and research along with lessons learned from their ACP PCORI pragmatic randomized control trial.
Grand Rounds 51: COVID Vaccination among Medicare Beneficiaries: Findings from an IMPACT Supplement (Slides)12/19/2024Funded Investigator
(Slides) In this Grand Rounds, Kaley Hayes, PharmD, PhD & Daniel Harris, PhD, MPH discuss the COVid VAXines Effects on the Aged (COVVAXAGE) database, which was the first project with NIA LINKAGE program (external data linkage to CMS data in NIA-funded projects); they walk through associated papers and lessons learned working with industry partners CVS and Walgreens.
Grand Rounds 51: COVID Vaccination among Medicare Beneficiaries: Findings from an IMPACT Supplement (Video)12/19/2024Funded Investigator
(Video) In this Grand Rounds, Kaley Hayes, PharmD, PhD & Daniel Harris, PhD, MPH discuss the COVid VAXines Effects on the Aged (COVVAXAGE) database, which was the first project with NIA LINKAGE program (external data linkage to CMS data in NIA-funded projects); they walk through associated papers and lessons learned working with industry partners CVS and Walgreens.
Grand Rounds 50: Using Pilot Studies to Inform ePCTs in Hispanic/Latino People Living with Dementia and their Care Partners (Slides)10/17/2024Funded Investigator
(Slides)  In this Grand Rounds, Maggie Ramirez, PhD, MS, MS, and Rafael Samper-Ternent, MD, PhD, describe "Using Pilot Studies to Inform ePCTs in Hispanic/Latino People Living with Dementia and their Care Partners"
Grand Rounds 50: Using Pilot Studies to Inform ePCTs in Hispanic/Latino People Living with Dementia and their Care Partners (Video)10/17/2024Funded Investigator
(Video)  In this Grand Rounds, Maggie Ramirez, PhD, MS, MS, and Rafael Samper-Ternent, MD, PhD, describe "Using Pilot Studies to Inform ePCTs in Hispanic/Latino People Living with Dementia and their Care Partners"
Grand Rounds 49: Evidence for Reducing Infections, Hospitalizations, and Antibiotic Resistant Pathogens in Nursing Homes through Universal Nasal Decolonization & Bathing with Chlorhexidine (Slides)9/19/2024Special Grand Rounds
(Slides) In this Grand Rounds, Susan Huang, MD, MPH, presents on "Evidence for Reducing Infections, Hospitalizations, and Antibiotic Resistant Pathogens in Nursing Homes through Universal Nasal Decolonization & Bathing with Chlorhexidine."
Grand Rounds 49: Evidence for Reducing Infections, Hospitalizations, and Antibiotic Resistant Pathogens in Nursing Homes through Universal Nasal Decolonization & Bathing with Chlorhexidine (Video)9/19/2024Special Grand Rounds
(Video) In this Grand Rounds, Susan Huang, MD, MPH, presents on "Evidence for Reducing Infections, Hospitalizations, and Antibiotic Resistant Pathogens in Nursing Homes through Universal Nasal Decolonization & Bathing with Chlorhexidine."
Grand Rounds 48: Current and future use of RE-AIM and its PRISM expansion, and their application in pragmatic trials (Slides)6/20/2024Implementation Core
(Slides) In Grand Rounds 48, Dr. Glasgow details RE-AIM and PRISM, an integrated framework designed to improve the adoption and sustainable implementation of evidence-based interventions in a wide range of public health, educational, community, and other settings.
Grand Rounds 48: Current and future use of RE-AIM and its PRISM expansion, and their application in pragmatic trials (Video)6/20/2024Implementation Core
(Video) In Grand Rounds 48, Dr. Glasgow details RE-AIM and PRISM, an integrated framework designed to improve the adoption and sustainable implementation of evidence-based interventions in a wide range of public health, educational, community, and other settings.
Grand Rounds 47: The GUIDE Model (Video)5/16/2024Stakeholder Engagement Team
(Video) In Grand Rounds 47, Drs. Epstein-Lubow and Lees-Haggerty, along with Tonya Saffer, Director of the Division of Healthcare Payment Models with the Centers for Medicare & Medicaid Services (CMS), share the GUIDE Model. GUIDE is a CMS payment model that tests whether dementia care programs can improve quality of life for people living with dementia and their caregivers.
Grand Rounds 47: The GUIDE Model (Slides)5/16/2024Stakeholder Engagement Team
(Slides) In Grand Rounds 47, Drs. Epstein-Lubow and Lees-Haggerty, along with Tonya Saffer, Director of the Division of Healthcare Payment Models with the Centers for Medicare & Medicaid Services (CMS), share the GUIDE Model. GUIDE is a CMS payment model that tests whether dementia care programs can improve quality of life for people living with dementia and their caregivers.
Grand Rounds 46: The WHELD Programme (Slides)4/18/2024
(Slides) In this Grand Rounds, Clive Ballard, MD, MPH, speaks on the WHELD Programme  – an evidence-based program developed to coach and support care home staff to deliver better person-centered care and increase opportunities for social interactions with personalized activities for residents living with dementia.
Grand Rounds 46: The WHELD Programme (video)4/18/2024
(Video) In this Grand Rounds, Clive Ballard, MD, MPH, speaks on the WHELD Programme  – an evidence-based program developed to coach and support care home staff to deliver better person-centered care and increase opportunities for social interactions with personalized activities for residents living with dementia.
Grand Rounds 45: Diagnosed Dementia in Medicare: Benchmarking for Study Planning and Equity (Video)3/21/2024Technical Data Core
(Video) In this Grand Rounds, Julie Bynum, MD, MPH, shares the pros and cons of using healthcare-generated data--such as Medicare Fee-for-Service and Medicare Advantage--to identify people living with Alzheimer's disease and related dementias, as well as the use of population benchmarcks in study planning and integrating health equity.
Grand Rounds 45: Diagnosed Dementia in Medicare: Benchmarking for Study Planning and Equity (Slides)3/21/2024Technical Data Core
(Slides) In this Grand Rounds, Julie Bynum, MD, MPH, shares the pros and cons of using healthcare-generated data--such as Medicare Fee-for-Service and Medicare Advantage--to identify people living with Alzheimer's disease and related dementias, as well as the use of population benchmarcks in study planning and integrating health equity.
Grand Rounds 44: Cultural adaptation of ADRD clinical trials for Latino participants (Video)2/16/2024Patient and Caregiver Relevant Outcomes Core
(Video) In this Grand Rounds, Drs Hanson, Lum, Ramirez-Gomez, and Fischer, discuss barriers to inclusivity in ADRD clinical trials, disparities in caregiving of PLWD, the importance of integrating cultural adaptations and lessons learned from the ADRD-PC trial.
Grand Rounds 44: Cultural adaptation of ADRD clinical trials for Latino participants (Slides)2/16/2024Patient and Caregiver Relevant Outcomes Core
(Slides) In this Grand Rounds, Drs Hanson, Lum, Ramirez-Gomez, and Fischer, discuss barriers to inclusivity in ADRD clinical trials, disparities in caregiving of PLWD, the importance of integrating cultural adaptations and lessons learned from the ADRD-PC trial.
Grand Rounds 43: Strategies to Implement ePCTs in Home and Community-Based Settings -- Issues and Successes in Assisted Living and Adult Day Centers (Video)1/25/2024
(Video) In this Grand Rounds, Sheryl Zimmerman, PhD, MSW, Ellen McCreedy, PhD, MPH, and Tina Sadarangani, PhD, RN, discuss common challenges that arise when conducting ePCTs in home and community-based, long-term care settings and present on suitable solutions to address these challenges.
Grand Rounds 43: Strategies to Implement ePCTs in Home and Community-Based Settings -- Issues and Successes in Assisted Living and Adult Day Centers (Slides)1/25/2024
(Slides) In this Grand Rounds, Sheryl Zimmerman, PhD, MSW, Ellen McCreedy, PhD, MPH, and Tina Sadarangani, PhD, RN, discuss common challenges that arise when conducting ePCTs in home and community-based, long-term care settings and present on suitable solutions to address these challenges.
Grand Rounds 42: The Clinical Implementation of Alzheimer's Disease Biomarkers (Video)12/21/2023Ethics and Regulation Core
(Video) In this Grand Rounds, Kyra O'Brien, MD, and Nicole Fowler, PhD, MHSA, discuss the landscape of Alzheimer's disease (AD) biomarker testing, dive into the potential clinical usefulness of plasma AD biomarkers, and identify the obstacles that hinder the implementation of plasma AD biomarkers.
Grand Rounds 42: The Clinical Implementation of Alzheimer's Disease Biomarkers (Slides)12/21/2023Ethics and Regulation Core
(Slides) In this Grand Rounds, Kyra O'Brien, MD, and Nicole Fowler, PhD, MHSA, discuss the landscape of Alzheimer's disease (AD) biomarker testing, dive into the potential clinical usefulness of plasma AD biomarkers, and identify the obstacles that hinder the implementation of plasma AD biomarkers.
Grand Rounds 41: Outcomes Truncated by Death in Randomized Trials (Video)11/16/2023
(Video) In this Grand Rounds, Michael Harhay, PhD, MPH, addresses the impact of intercurrent events, specifically the occurrence of death in patients with critical illness during research studies, which can lead to missing outcome data and potentially biased results. He discusses various approaches, such as composite outcomes, to navigate complexities of this missing data issue.
Grand Rounds 41: Outcomes Truncated by Death in Randomized Trials (Slides)11/16/2023
(Slides) In this Grand Rounds, Michael Harhay, PhD, MPH, addresses the impact of intercurrent events, specifically the occurrence of death in patients with critical illness during research studies, which can lead to missing outcome data and potentially biased results. He discusses various approaches, such as composite outcomes, to navigate complexities of this missing data issue.
Grand Rounds 40: Electronic Nudges and Pragmatic Trials to Improve Hospital Palliative Care Delivery (Video)10/19/2023Implementation Core
(Video) In this Grand Rounds, Katherine Courtright, MD, MSHP, shares the integration of systematic referral criteria with behavioral insights to nudge clinicians, offering a low-cost, scalable, and powerful approach to promote palliative care delivery.
Grand Rounds 40: Electronic Nudges and Pragmatic Trials to Improve Hospital Palliative Care Delivery (Slides)10/19/2023Implementation Core
(Slides) In this Grand Rounds, Katherine Courtright, MD, MSHP, shares the integration of systematic referral criteria with behavioral insights to nudge clinicians, offering a low-cost, scalable, and powerful approach to promote palliative care delivery.
Grand Rounds 39: Decision Architecture Randomization Trials: Extremely Low-Cost Trials with Preservation of Clinician and Patient Choice (Video)9/21/2023
(Video) In this Grand Rounds, James Flory, MD, MSCE, introduces an innovative trial design known as Decision Architecture Randomization Trials (DART), which aims to utilize the "decision architecture" of electronic health records to incorporate randomized nudges into various prescribing decisions.
Grand Rounds 39: Decision Architecture Randomization Trials: Extremely Low-Cost Trials with Preservation of Clinician and Patient Choice (Slides)9/21/2023
(Slides) In this Grand Rounds, James Flory, MD, MSCE, introduces an innovative trial design known as Decision Architecture Randomization Trials (DART), which aims to utilize the "decision architecture" of electronic health records to incorporate randomized nudges into various prescribing decisions.
1 - 30Next